LSZ

LSZ, also known as Lysergic acid 2,4-dimethylazetidide, is a hallucinogenic drug and an analogue of LSD developed by the team led by David E. Nichols at Purdue University. While LSZ has subtly different effects than LSD, it appears to be slightly longer lasting and slightly more potent.

Dosage

Light: 100-150 μg

Common: 150-300 μg

Strong: 300+ μg

Duration

Onset: 90-120 minutes

Total: 7-10 hours

Effects

While LSD has subtly different effects than LSD, it appears to be slightly longer lasting while also having a longer comeup.

Harm Reduction

While widespread use of LSZ is relatively new and therefore its full impact is unknown, it is likely that it has a similar safety profile to LSD. Refer to LSD and Psychedelic Harm Reduction for more information.

Legal status

America

Controlled in the United States via the Federal Analog Act but only if it is intended for human consumption.